Companies: 10,144     total market cap: NZ$191.175 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$HKD🇭🇰$SGD🇸🇬
Regulus Therapeutics
RGLS
#8796
Rank
NZ$0.15 B
Marketcap
🇺🇸 United States
Country
$2.44
Share price
-4.67%
Change (1 day)
8.37%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories

P/S ratio for Regulus Therapeutics (RGLS)

P/S ratio as of November 2024 (TTM): N/A

According to Regulus Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9540. At the end of 2024 the company had a P/S ratio of N/A.

P/S ratio history for Regulus Therapeutics from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024N/A
2023N/A
2022N/A
2021N/A-100%
20208.57212.92%
20192.74-97.6%
2018114-92.41%
2017> 10001405.64%
201699.7350.77%
201522.1-78.39%
2014102548.71%
201315.8-11.22%
201217.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
GlaxoSmithKline
GSK
1.71N/A🇬🇧 UK
Sanofi
SNY
2.36N/A🇫🇷 France
Biogen
BIIB
2.42N/A🇺🇸 USA
AstraZeneca
AZN
4.01N/A🇬🇧 UK
Alnylam Pharmaceuticals
ALNY
15.0N/A🇺🇸 USA
Sangamo Therapeutics
SGMO
34.1N/A🇺🇸 USA
Bristol-Myers Squibb
BMY
2.42N/A🇺🇸 USA
Dicerna Pharmaceuticals
DRNA
N/AN/A🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com